Vagina Cancer

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 2781 Experts worldwide ranked by ideXlab platform

Jianhui Cai - One of the best experts on this subject based on the ideXlab platform.

  • Brachytherapy in the treatment of breast Cancer.
    International journal of clinical oncology, 2017
    Co-Authors: Xinna Deng, Fei Gao, Shuzhen Liu, Jianhui Cai
    Abstract:

    Brachytherapy is an important radio-therapeutic modality for a variety of malignancies, including prostate Cancer, cervix Cancer, breast Cancer, Vagina Cancer, endometrium Cancer, head and neck Cancer, and many more. This technique has been shown to be an effective and safe non-pharmaceutical treatment with fewer serious complications and better outcome than other treatments for breast Cancer. Every year, hundreds of thousands of patients around the world benefit from brachytherapy, which reliably delivers a relatively higher radiation dose to the intended target. However, the follow-up time, patient eligibility criteria, treatment strategy, and radiation doses used in published studies are somewhat inconsistent, making it difficult to strictly compare and evaluate the performance of the treatment. More rigorous studies are required to confirm the safety of this technique and to make outcome data more comparable. In this review, we focus on recent advances in breast brachytherapy techniques and provide an overview of outcomes, cosmetic outcome, toxicity, complications, and limitations of brachytherapy for the treatment of breast Cancer. We also summarize the clinical outcomes and toxicity results in patients receiving or not receiving brachytherapy.

Xinna Deng - One of the best experts on this subject based on the ideXlab platform.

  • Brachytherapy in the treatment of breast Cancer.
    International journal of clinical oncology, 2017
    Co-Authors: Xinna Deng, Fei Gao, Shuzhen Liu, Jianhui Cai
    Abstract:

    Brachytherapy is an important radio-therapeutic modality for a variety of malignancies, including prostate Cancer, cervix Cancer, breast Cancer, Vagina Cancer, endometrium Cancer, head and neck Cancer, and many more. This technique has been shown to be an effective and safe non-pharmaceutical treatment with fewer serious complications and better outcome than other treatments for breast Cancer. Every year, hundreds of thousands of patients around the world benefit from brachytherapy, which reliably delivers a relatively higher radiation dose to the intended target. However, the follow-up time, patient eligibility criteria, treatment strategy, and radiation doses used in published studies are somewhat inconsistent, making it difficult to strictly compare and evaluate the performance of the treatment. More rigorous studies are required to confirm the safety of this technique and to make outcome data more comparable. In this review, we focus on recent advances in breast brachytherapy techniques and provide an overview of outcomes, cosmetic outcome, toxicity, complications, and limitations of brachytherapy for the treatment of breast Cancer. We also summarize the clinical outcomes and toxicity results in patients receiving or not receiving brachytherapy.

O. A. Anurova - One of the best experts on this subject based on the ideXlab platform.

  • Female reproductive system tumors with Merkel cell phenotype
    Russian Journal of Oncology, 2016
    Co-Authors: Seda O. Nikogosyan, T. Sh Tagibova, V. V. Kuznetsov, O. A. Anurova
    Abstract:

    Diagnostics and treatment of female reproductive system tumors with Merkel cell phenotype, rare aggressive tumors with dismal prognosis, is under consideration in this article. Only 20 cases of Merkel cell vulvar carcinoma and 1 case of Merkel cell Vagina Cancer were described in the literature. Diagnostics must include immunohistochemical analysis, as expression of cytokeratine 20 proves to be the most typical factor. Polyomavirus infection is believed to be associated with the disease pathogenesis. No treatment standards were accepted due to the rarity of the disease. Considering the data on tumor radiosensitivity, the treatment must include radio- or chemoradiotherapy.

Fei Gao - One of the best experts on this subject based on the ideXlab platform.

  • Brachytherapy in the treatment of breast Cancer.
    International journal of clinical oncology, 2017
    Co-Authors: Xinna Deng, Fei Gao, Shuzhen Liu, Jianhui Cai
    Abstract:

    Brachytherapy is an important radio-therapeutic modality for a variety of malignancies, including prostate Cancer, cervix Cancer, breast Cancer, Vagina Cancer, endometrium Cancer, head and neck Cancer, and many more. This technique has been shown to be an effective and safe non-pharmaceutical treatment with fewer serious complications and better outcome than other treatments for breast Cancer. Every year, hundreds of thousands of patients around the world benefit from brachytherapy, which reliably delivers a relatively higher radiation dose to the intended target. However, the follow-up time, patient eligibility criteria, treatment strategy, and radiation doses used in published studies are somewhat inconsistent, making it difficult to strictly compare and evaluate the performance of the treatment. More rigorous studies are required to confirm the safety of this technique and to make outcome data more comparable. In this review, we focus on recent advances in breast brachytherapy techniques and provide an overview of outcomes, cosmetic outcome, toxicity, complications, and limitations of brachytherapy for the treatment of breast Cancer. We also summarize the clinical outcomes and toxicity results in patients receiving or not receiving brachytherapy.

Shuzhen Liu - One of the best experts on this subject based on the ideXlab platform.

  • Brachytherapy in the treatment of breast Cancer.
    International journal of clinical oncology, 2017
    Co-Authors: Xinna Deng, Fei Gao, Shuzhen Liu, Jianhui Cai
    Abstract:

    Brachytherapy is an important radio-therapeutic modality for a variety of malignancies, including prostate Cancer, cervix Cancer, breast Cancer, Vagina Cancer, endometrium Cancer, head and neck Cancer, and many more. This technique has been shown to be an effective and safe non-pharmaceutical treatment with fewer serious complications and better outcome than other treatments for breast Cancer. Every year, hundreds of thousands of patients around the world benefit from brachytherapy, which reliably delivers a relatively higher radiation dose to the intended target. However, the follow-up time, patient eligibility criteria, treatment strategy, and radiation doses used in published studies are somewhat inconsistent, making it difficult to strictly compare and evaluate the performance of the treatment. More rigorous studies are required to confirm the safety of this technique and to make outcome data more comparable. In this review, we focus on recent advances in breast brachytherapy techniques and provide an overview of outcomes, cosmetic outcome, toxicity, complications, and limitations of brachytherapy for the treatment of breast Cancer. We also summarize the clinical outcomes and toxicity results in patients receiving or not receiving brachytherapy.